IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study

Recently, it has been shown that some well-known pathogenic mediators in rheumatoid arthritis (RA), such as interleukin-1β (IL-1β) and tumor necrosis factor (TNF), could play a pathogenic role in insulin resistance and (IR) and type 2 diabetes (T2D). In this 6-month longitudinal study, we aimed at i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruscitti, Piero, Ursini, Francesco, Cipriani, Paola, Greco, Marta, Alvaro, Saverio, Vasiliki, Liakouli, Di Benedetto, Paola, Carubbi, Francesco, Berardicurti, Onorina, Gulletta, Elio, De Sarro, Giovambattista, Giacomelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408058/
https://www.ncbi.nlm.nih.gov/pubmed/30762811
http://dx.doi.org/10.1097/MD.0000000000014587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408058/
https://www.ncbi.nlm.nih.gov/pubmed/30762811
http://dx.doi.org/10.1097/MD.0000000000014587

Ejemplares similares